Risk factors for non-adherence of HIV/AIDS patients to a highly active antiretroviral therapy

2.50
Hdl Handle:
http://hdl.handle.net/10755/151245
Type:
Presentation
Title:
Risk factors for non-adherence of HIV/AIDS patients to a highly active antiretroviral therapy
Abstract:
Risk factors for non-adherence of HIV/AIDS patients to a highly active antiretroviral therapy
Conference Sponsor:Sigma Theta Tau International
Conference Year:2007
Author:Colombrini, Maria Rosa C., RN
P.I. Institution Name:State University of Campinas
Title:Director of Service, Master degree
Co-Authors:Marilia F. Coleta, PhD and Maria Helena Baena de Moraes Lopes, PhD
[Research Presentation] Background: to measure the adherence and non-adherence to a highly active antiretroviral therapy (HAART); to identify some of factors related to HAART non-adherence; to establish the predictive values of the factors associated with non-adherence to HAART. Method: analytical study of prevalence. This study was accomplished at the AIDS Day Unit, Clinical Hospital, State University of Campinas (UNICAMP), Campinas, Sao Paulo, Brazil. Sixty patients were selected and interviewed in March 2002. Considering the three days before the interview, they were classified as adherent: intake of 95% or more of the total number of pills prescribed. Results: adherence was 73.3% in the 95% criterion. The multivariate logistic regression analysis using the Stepwise selection indicated: the risk of non-adherence was 6.48 fold greater in the African Brazilian race; the absence of side effects presented a 7.6 fold risk that increased by 12% at each pill intake, which means that the risk was 1.12. Conclusions: the adherence observed was higher than the one found in literature. It is evident the need for an in-depth investigation of the predictive factors and the suggestion that socio-demographic and cultural factors may interfere in treatment adherence to HAART. A professional should, therefore, be well informed about the population he treats so specific interventions that favor the improvement of adherence to the HAART treatment can be adopted. KEY-WORDS: adherence; HIV; infectious diseases; risk factors; antiretroviral therapy
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleRisk factors for non-adherence of HIV/AIDS patients to a highly active antiretroviral therapyen_GB
dc.identifier.urihttp://hdl.handle.net/10755/151245-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Risk factors for non-adherence of HIV/AIDS patients to a highly active antiretroviral therapy</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2007</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Colombrini, Maria Rosa C., RN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">State University of Campinas</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Director of Service, Master degree</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">ceccatoc@hc.unicamp.br</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">Marilia F. Coleta, PhD and Maria Helena Baena de Moraes Lopes, PhD</td></tr><tr><td colspan="2" class="item-abstract">[Research Presentation] Background: to measure the adherence and non-adherence to a highly active antiretroviral therapy (HAART); to identify some of factors related to HAART non-adherence; to establish the predictive values of the factors associated with non-adherence to HAART. Method: analytical study of prevalence. This study was accomplished at the AIDS Day Unit, Clinical Hospital, State University of Campinas (UNICAMP), Campinas, Sao Paulo, Brazil. Sixty patients were selected and interviewed in March 2002. Considering the three days before the interview, they were classified as adherent: intake of 95% or more of the total number of pills prescribed. Results: adherence was 73.3% in the 95% criterion. The multivariate logistic regression analysis using the Stepwise selection indicated: the risk of non-adherence was 6.48 fold greater in the African Brazilian race; the absence of side effects presented a 7.6 fold risk that increased by 12% at each pill intake, which means that the risk was 1.12. Conclusions: the adherence observed was higher than the one found in literature. It is evident the need for an in-depth investigation of the predictive factors and the suggestion that socio-demographic and cultural factors may interfere in treatment adherence to HAART. A professional should, therefore, be well informed about the population he treats so specific interventions that favor the improvement of adherence to the HAART treatment can be adopted. KEY-WORDS: adherence; HIV; infectious diseases; risk factors; antiretroviral therapy</td></tr></table>en_GB
dc.date.available2011-10-26T10:56:15Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T10:56:15Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.